U.S. markets closed

AbbVie Earnings Beat, Revenue Inline In Q4

AbbVie Earnings Beat, Revenue Inline In Q4

Investing.com - AbbVie reported on Friday fourth quarter earnings that beat analysts' forecasts and revenue that was inline with expectations.

AbbVie announced earnings per share of $2.21 on revenue of $8.70B. Analysts polled by Investing.com anticipated EPS of $2.19 on revenue of $8.7B. That with comparison to EPS of $1.9 on revenue of $8.31B in the same period a year before. AbbVie had reported EPS of $2.33 on revenue of $8.48B in the previous quarter. Analysts are expecting EPS of $2.11 and revenue of $8.02B in the upcoming quarter.

AbbVie shares are down 1% from the beginning of the year , still down 5.23% from its 52 week high of $91.99 set on December 20, 2019. They are under-performing the S&P 500 which is up 3.12% year to date.

AbbVie shares gained 1.86% in pre-market trade after the report.


AbbVie follows other major Healthcare sector earnings this month

AbbVie's report follows an earnings beat by J&J on January 22, who reported EPS of $1.88 on revenue of $20.75B, compared to forecasts EPS of $1.87 on revenue of $20.8B.

Novartis ADR had beat expectations on January 29 with fourth quarter EPS of $1.32 on revenue of $12.4B, compared to forecast for EPS of $1.31 on revenue of $12.33B.

Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar

Related Articles

Malaysia sovereign fund asks news website to stop reports on airline sale

Onetime Billionaire Says He’s Now Worth Nothing 

AbbVie leans on new treatments to forecast upbeat 2020 profit